Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program
Author(s) -
Ashley E. Ross,
Stacy Loeb,
Patricia Landis,
Alan W. Partin,
Jonathan I. Epstein,
Anna Kettermann,
Zhaoyong Feng,
H. Ballentine Carter,
Patrick C. Walsh
Publication year - 2010
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2009.25.7311
Subject(s) - medicine , biopsy , prostatectomy , prostate cancer , receiver operating characteristic , prostate specific antigen , urology , prostate biopsy , cancer , prostate
To assess the predictive ability of prostate-specific antigen (PSA) velocity (PSAV) and doubling time (PSADT) for biopsy progression and adverse pathology at prostatectomy among men with low-risk prostate cancer enrolled on an active-surveillance program.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom